Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 13/20 | 0.64 |
| ▸ | MAOA | P21397 | 3/20 | 0.64 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.56 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7950720 | 0.82 | MAOB (0.79) | MAOBMAOA | |
| SCHEMBL8712698 | 0.77 | MAOB (0.59) | MAOBMAOATSHRALDH1A1 | |
| SCHEMBL3350981 | 0.77 | MAOB (0.65) | MAOBMAOATSHRALDH1A1 | |
| SCHEMBL7944024 | 0.76 | MAOA (0.60) | MAOBMAOAMTNR1A | |
| SCHEMBL3345973 | 0.74 | MAOB (0.51) | MAOBMAOA | |
| SCHEMBL21543811 | 0.74 | MAOA (0.55) | MAOBMAOATSHRALDH1A1PLA2G2A | |
| SCHEMBL2746940 | 0.73 | MAOB (0.85) | MAOBMAOATSHRALDH1A1 | |
| SCHEMBL10381205 | 0.73 | MAOB (0.71) | MAOBMAOAALDH1A1 | |
| SCHEMBL16482859 | 0.73 | MAOA (0.54) | MAOBMAOAALDH1A1PLA2G2A | |
| SCHEMBL2601407 | 0.73 | MAOB (0.41) | MAOBMAOATSHRALDH1A1PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6218427-B1 | AS ENDOTHELIN RECEPTOR ANTAGONIST | SHIONOGI & CO., LTD. (JP) | 2001-04-17 | — | — | US | disclosed |
| EP-0924207-A1 | CHROMENE-3-CARBOXYLATE DERIVATIVES | SHIONOGI & CO., LTD. (JP) | 1999-06-23 | — | — | EP | disclosed |